BSECompany Update10 Aug 2026 · 10 Aug 2026, 08:49 pm

As per enclosed file

Pine Labs Ltd · 544606

✦ AI SummaryESG

Pine Labs Ltd has disclosed the grant of 15,88,789 employee stock options to eligible employees under the Pine Labs Employee Stock Option Plan 2025, within the approved limit of 10,20,98,072 stock options by the shareholders.

Analysis Scores

Earnings Impact5/10
Growth Catalyst6/10
Governance Concern2/10
Regulatory Risk1/10
Balance Sheet Risk1/10
Liquidity Impact8/10
Market Sentiment6/10

✦ Ask a Question

Ask anything about this announcement — AI will answer based on the filing content.

0/500

Full Announcement

Pine Labs Ltd - 544606 - Announcement Under Regulation 30 (LODR)-Updates (Grant Of ESOP)

Attachments (1)

📄

03e24940-77a6-48af-9534-a080dcebe3fc.pdf

pdf

Download →
View document text
Date: August 10, 2026 BSE Limited, National Stock Exchange of India Limited, 20th Floor, P.J. Towers, Exchange Plaza, C-1, Block G, Dalal Street, Bandra Kurla Complex, Bandra (E), Mumbai - 400001. Mumbai – 400 051 BSE Scrip Code: 544606 NSE Scrip Symbol: PINELABS Dear Sir/Ma’am, Subject: Disclosure under Regulation 30 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015 Pursuant to Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 read with Schedule III, we would like to inform that, the Nomination and Remuneration Committee (“NRC”) of Pine Labs Limited (“the Company”) at its meeting held today, i.e. on August 10, 2026, has approved the grant of 15,88,789 employee stock options to the eligible employees under Pine Labs Employee Stock Option Plan 2025 (“ESOP Scheme”) of the Company, within the approved limit of 10,20,98,072 stock options by the shareholders. The required information, in compliance with Para B of Part A of Schedule III to the SEBI Listing Regulations read with the SEBI Circular No. HO/49/14/14(7)2025-CFD-POD2/I/3762/2026 dated January 30, 2026, is enclosed as Annexure A. The above information will also be available on the website of the Company at https://www.pinelabs.com/investor- relations. You are requested to take the same on record. Thank You. For Pine Labs Limited Neerav Mehta Company Secretary and Compliance Officer Membership Number: A20949 Encl: a/a ANNEXURE-A Details required under Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 read with SEBI Master Circular No. HO/49/14/14(7)2025-CFD-POD2/I/3762/2026 dated January 30, 2026 Sl. No. Particulars Details 1 Brief details of stock options granted 15,88,789 Options were granted to eligible employees by Nomination and Remuneration Committee under Pine Labs Employee Stock Option Plan 2025. 2 Whether the scheme is in terms of SEBI (Share Yes Based Employees Benefits and Sweat Equity) Regulations, 2021 3 Total number of shares covered by these options 15,88,789 (Each stock option is convertible into one fully paid-up equity share having a face value of INR 1 each). 4 Pricing formula (Exercise Price) 14,29,976 Options at INR 136.61 per stock option calculated as Volume Adjusted Weighted Average Price of last 3 months, discounted by 10% 1,58,813 Options at INR 5.40 per stock option 5 Options vested/Vesting Schedule Options vested - Nil stock options out of 15,88,789 have been vested so far. Vesting schedule – 15,64,188 Options - vesting period 48 months. 1st vesting of 25% - on completion of 12 months from grant date, thereafter monthly vesting. 24,601 Options – vesting period 20 to 36 months. 1st vesting of 25% - on completion of 12 months from grant date, thereafter monthly vesting. 6 Time within which option may be exercised; The exercise period shall be 5 years from the date of vesting subject to the terms and conditions of the Scheme. 7 Options exercised Not Applicable. 8 Money realized by exercise of Options Not Applicable 9 The total number of shares arising as a result of Not Applicable exercise of Options 10 Options lapsed Not Applicable 11 Variation in terms of Options Not Applicable 12 Brief details of significant terms In addition to terms related to exercise price as per Sl. No. 4 and vesting schedule as per Sl. No. 5 above, the grantee should be an active employee on the date of vesting. Sl. No. Particulars Details 13 Subsequent changes or cancellation or exercise of Not Applicable such Options 14 Diluted earnings per share pursuant to the issue of Not Applicable equity shares on exercise of Options